BioCardia, Inc. (BCDA) Balance Sheet

NASDAQ: BCDAAssets, liabilities, debt and equity over 10 years.

BCDA balance sheet, 2025

December 31, 2025 · U.S. dollars

$3.4M assets = $2.5M liabilities + $895,000 equity

What it owns$3.4MCash & ST investments: $2.5M (73.1%)Cash & ST investments$2.5M · 73%Receivables: $20,000 (0.6%)Other current: $216,000 (6.3%)Other current $216,000PP&E: $510,000 (14.9%)PP&E$510,000 · 15%Other non-current: $171,000 (5.0%)=How it is financed$3.4MCurrent liabilities: $2.4M (71.3%)Current liabilities$2.4M · 71%Other LT liabilities: $86,000 (2.5%)Shareholders’ equity: $895,000 (26.2%)Shareholders’ equity$895,000 · 26%

Both columns are drawn to the same scale: what BCDA owns equals what it owes plus shareholders’ equity. Hover a block for its value.

BCDA financial health

Current ratio1.12
Adequate · current assets cover current liabilities 1.12×
Debt / equity0.59
Moderate leverage · $0.59 of debt for each $1 of equity
Equity / assets26.2%
Balanced · of assets funded by shareholders
Cash / debt472.7%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

BCDA balance sheet trends, 2016–2025

BioCardia, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$22.1M2016$3.4M2025−18.7%/yr
Total liabilities$1.5M2016$2.5M2025+5.9%/yr
Shareholders’ equity$20.6M2016$895,0002025−29.4%/yr
Cash & short-term investments$21.4M2016$2.5M2025−21.2%/yr
Total debt$478,0002016$528,0002025+1.1%/yr
Net cash (debt)$20.9M2016$2.0M2025−$18.9M
Working capital$20.5M2016$300,0002025−$20.2M
Book value per share$2.622017$0.132025−31.0%/yr
Current ratio15.1820161.122025−14.05
Debt / equity0.0220160.592025+0.57
Shares outstanding4.2M20176.7M2025+5.8%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

BCDA assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

BCDA liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

BCDA debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

BCDA balance sheet

BioCardia, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$2.5M$2.4M$1.1M$7.4M$12.9M$21.4M$5.6M$5.4M$12.7M$21.4M
Cash & equivalents$2.5M$2.4M$1.1M$7.4M$12.9M$21.4M$5.6M$5.4M$12.7M$21.4M
Receivables$20,000$0$63,000$201,000$147,000$232,000$147,000$274,000$95,000$74,000
Inventory$0$0$0−$201,000$1−$850,000$4,000$141,000$191,000$135,000
Other current assets$216,000$251,000$295,000$501,000$461,999$1.9M$642,000$445,000$340,000$356,000
Total current assets$2.7M$2.6M$1.5M$7.9M$13.5M$22.7M$6.4M$6.2M$13.3M$21.9M
Property, plant & equipment (net)$510,000$931,000$1.4M$1.8M$2.1M$712,000$1.2M$145,000$169,000$111,000
Goodwill & intangible assets$0$0$0$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$171,000$171,000$170,000$172,000$172,000$54,000$54,000$54,000$54,000$54,000
Total assets$3.4M$3.7M$3.0M$9.8M$15.7M$23.4M$7.7M$6.4M$13.5M$22.1M
Liabilities
Accounts payable$641,000$385,000$890,000$683,000$507,000$746,000$914,000$743,000$902,000$525,000
Short-term debt$442,000$385,000$333,000$315,000$237,000$614,000$528,000—$124,000$478,000
Deferred revenue$535,000$532,000$561,000$965,000$1.5M$683,000$732,000$757,000$891,000$441,000
Total current liabilities$2.4M$2.3M$3.6M$3.6M$3.7M$4.2M$4.0M$2.5M$2.3M$1.4M
Long-term debt$0$0$0$0$0$0$0$0$0$0
Lease obligations$528,000$951,000$1.3M$1.6M$1.9M$614,000$1.1M———
Other long-term liabilities$86,000$566,000$982,000$1.3M$1.6M$2.7M$1.3M$77,000$81,000$56,000
Total liabilities$2.5M$2.9M$4.6M$4.9M$5.3M$4.2M$5.3M$2.6M$2.4M$1.5M
Shareholders' equity
Common stock & paid-in capital$11,000$5,000$2,000$20,000$17,000$16,000$7,000$43,000$38,000$458,000
Retained earnings (deficit)−$168.3M−$160.1M−$152.2M−$140.6M−$128.7M−$116.1M−$101.1M−$86.4M−$72.5M−$60.1M
Accumulated other comprehensive income———$0—$0$0$0−$758,000−$771,000
Total shareholders' equity$895,000$837,000−$1.6M$4.9M$10.4M$19.2M$2.4M$3.8M$11.1M$20.6M
Key figures
Total debt$528,000$951,000$1.3M$1.6M$1.9M$614,000$1.1M—$124,000$478,000
Net cash (debt)$2.0M$1.4M−$212,000$5.7M$11.0M$20.8M$4.4M—$12.6M$20.9M
Working capital$300,000$301,000−$2.1M$4.3M$9.8M$18.4M$2.4M$3.7M$11.0M$20.5M
Tangible book value$895,000$837,000−$1.6M$4.9M$10.4M$19.2M$2.4M$3.8M$11.1M$20.6M
Book value per share$0.13———————$2.62—
Shares outstanding6.7M———————4.2M—
Current ratio1.121.130.402.193.635.331.592.445.7115.18
Quick ratio1.031.020.322.113.515.091.432.215.4814.84
Debt / equity0.591.14—0.330.180.030.48—0.010.02
Equity / assets26.2%22.5%−53.7%50.0%66.0%81.9%30.9%59.1%82.2%93.2%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 24, 2026); data from EODHD.

BCDA financial position

At the end of fiscal 2025 (December 31, 2025), BioCardia had total assets of $3.4 million (down 8.4% from a year earlier), total liabilities of $2.5 million and shareholders' equity of $0.9 million. It held $2.5 million in cash and short-term investments against $0.5 million of debt, a net cash position of $2.0 million. Its current ratio was 1.12. In the latest quarter (ended June 30, 2026) total assets were $4.8 million and equity $2.7 million.

Related: BCDA income statement, BCDA cash flow statement, BCDA key metrics. See the BCDA stock overview for the latest quote and news.

BCDA balance sheet FAQ

What are BioCardia's total assets?

BioCardia reported total assets of $3.4 million at the end of fiscal 2025 (December 31, 2025), compared with $3.7 million a year earlier.

How much debt does BioCardia have?

BioCardia had $0.5 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.59.

How much cash does BioCardia have?

BioCardia held $2.5 million in cash and short-term investments at the end of fiscal 2025; with $0.5 million of debt that is net cash of $2.0 million.

What is BioCardia's book value?

BioCardia's shareholders' equity (book value) was $0.9 million at the end of fiscal 2025, or $0.13 per share.

What is BioCardia's current ratio?

BioCardia had current assets of $2.7 million and current liabilities of $2.4 million, a current ratio of 1.12 (it can cover its short-term obligations).

Biotechnology: balance sheet